Drugs with Dosage: TABLET;BUCCAL
✉ Email this page to a colleague
Drugs with Dosage: TABLET;BUCCAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | Dosage |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax Labs | METHYLTESTOSTERONE | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 084287-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET;BUCCAL, SUBLINGUAL | ||||
Lilly | METHYLTESTOSTERONE | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 080256-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET;BUCCAL, SUBLINGUAL | ||||
Lilly | METHYLTESTOSTERONE | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 080256-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET;BUCCAL, SUBLINGUAL | ||||
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET;BUCCAL, SUBLINGUAL | ||||
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET;BUCCAL, SUBLINGUAL | ||||
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET;BUCCAL, SUBLINGUAL | ||||
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET;BUCCAL, SUBLINGUAL | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration | >Dosage |